- Home
- PBYI
as 11-15-2024 4:00pm EST
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 126.5M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 524.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.47 | EPS Growth: | 492.79 |
| 52 Week Low/High: | $2.23 - $7.73 | Next Earning Date: | 11-07-2024 |
| Revenue: | $243,569,000 | Revenue Growth: | 6.30% |
| Revenue Growth (this year): | -4.7% | Revenue Growth (next year): | -6.42% |
Latest Puma Biotechnology Inc News
PBYI Breaking Stock News: Dive into PBYI Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative
Simply Wall St.
8 days ago
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations
Zacks
9 days ago
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up
GuruFocus.com
10 days ago
Puma Biotechnology Inc (PBYI) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
Associated Press Finance
10 days ago
Puma Biotech: Q3 Earnings Snapshot
Business Wire
10 days ago
Puma Biotechnology Reports Third Quarter 2024 Financial Results
Business Wire
12 days ago
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
20 days ago
3 US Penny Stocks With Market Caps Under $700M
Compare PBYI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBYI Puma Biotechnology Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.